Recruiting studies
Crohn’s disease
Study
New study on Crohn’s Disease – Let’s fight inflammation in your gut
About the Merck-sponsored study:
Crohn's disease is a chronic inflammatory bowel disease that primarily affects the gastrointestinal tract.
It is characterized by periods of flare-ups and remissions, causing symptoms such as abdominal pain, diarrhea, severe fatigue and weight loss.
This complex and debilitating condition requires ongoing management and can greatly affect the quality of life of those affected.
Are you one of these people affected by this disease?
Our clinical study on Crohn's disease could potentially help you.
The treatments currently used are limited and more or less effective depending on each person.
For this reason, it is important to continue to develop new treatments suitable for everyone.
The current study tests an investigational drug that potentially reduces inflammation in the gut and could help with fibrotic scar tissue in the gut.
Why participate?
Contribute to the future of health: Your participation can play a crucial role in medical research with a drug potentially offering better reduction of intestinal inflammation linked to Crohn’s disease.
Access to care: benefiting from close study-related medical monitoring by the team as well as free examinations linked to studies and information on good lifestyle habits.
Financial Compensation: To recognize your time and dedication to the cause, financial compensation to cover study-related expenses may be considered for participants who meet the eligibility criteria.
Who is eligible?
We invite to participate individuals who:
Are aged 18 to 75
Have been diagnosed with Crohn's disease for at least 3 months
How does it work?
Pre-registration: Start by completing our online pre-registration form to help us determine if you may be eligible.
Initial Assessment: If you are considered pre-eligible, an invitation will be sent to you to come to our center for a detailed assessment.
Participation: After confirmation of your eligibility, you will receive all the information required to begin your participation in this study.
I want to apply to this clinical study
For more information, contact us at 581 477-3439 (Québec) or at 1-844-739-3439 (toll free), or fill the online form.
The study process in pictures
Explanation
Step 1 | Before starting the study, we will take time to fully explain the selection process and the conduct of the study by phone.
Meeting
Step 2 | After the initial phone interview, if you are still interested in taking part in a study, we schedule a preliminary meeting with you during which you may ask all the questions you wish and take the time you require to read over the consent form. This form explains, in detail, the different stages of each study.
Decision
Step 3 | You may make a decision at that time to move forward with or terminate the selection process. However, you are under no obligation to make an immediate decision. Based on briefing content, you may take the time necessary to come to a decision and consult with your personal physician or loved ones.
Tests
Step 4 | Depending on the nature of the study, some tests or medical examinations may be required. In the majority of cases, these tests or examinations are conducted on Diex Research premises based on your individual availability.
Departure
Step 5 | If you are eligible, you may then begin a clinical study with us.